Acute kidney injury (AKI) is a well-known complication of cancer. Etiology of AKI in cancer varies from acute tubular necrosis due to medication or sepsis, volume depletion, tumor lysis syndrome, and obstruction or infiltration of the kidneys. Presence of AKI leads to longer hospitalization and increased cost. It also increases mortality in patients with cancer, delays treatment, and increases toxicity of chemotherapy. However, very little is known about AKI in lymphoma.
To the best of knowledge, this is the largest report of AKI in lymphoma patients. A study revealed the presence of AKI in 31.8% of patients. The incidence of AKI in various cancers has been reported to be between 12 and 49%. Our study incidence is higher than that of another, which reports incidence of AKI (defined as 50% elevation of baseline serum creatinine) in 29.39% lymphoma patients. The discrepancy could be…